Despite fluctuating economic conditions across different geographical regions coupled with the respective regulatory pressures, the companies offering neurorehab devices and services are exhibiting adaptability and efficacy. Some of the key market players are Bioness, Inc., Ectron Ltd., Hocoma AG, Medtronic, and Tyromotion. Collaborations for novel product development and strengthening of distribution networks constitute some of the strategic initiatives implemented by key players. For instance, Ectron Ltd. has collaborated with Bioness, Inc. and Tyromotion for distribution of their products across different geographical regions.
Further Key Findings from the Study Suggest:
Neurorobotics is expected to be one of the most lucrative segments in the coming years owing to the high availability of exoskeletons and prosthetics targeted for treating movement disabilities. Bioness, Inc. and Hocoma AG are few of the key manufacturers of exoskeletons and prosthetics.
Consistent technological sophistications in brain stimulations and machine learning brain-computer interface segment is expected to develop tremendously.
Non invasive stimulators have the potential to modulate brain plasticity. In February 2016, USFDA approved Medtronic's brain stimulation therapy in the treatment of Parkinson's disease.
Read the full report: http://www.reportlinker.com/p04230390-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: email@example.com
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/neurorehabilitation-devices-market-by-products-by-therapy-area-and-segment-forecasts-to-2024-300347133.html